Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MKGAF
Recent news which mentions MKGAF
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
December 06, 2023
Tickers
MKGAF
MKKGY
SNY
Tags
Biotech
Market News
Health Care
From
Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
September 26, 2023
Tickers
MKGAF
MKKGY
RGEN
Tags
Analyst Ratings
Market News
MKGAF
From
Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
August 03, 2023
Tickers
MKGAF
MKKGY
Tags
Market News
MKKGY
Health Care
From
Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
Tickers
MKGAF
MKKGY
NVO
REGN
Tags
Market News
Biotech
RHHBF
From
Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
June 20, 2023
Tickers
A
ABCM
DHR
MKGAF
Tags
Briefs
News
General
From
Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
May 17, 2023
Tickers
MKGAF
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Market News
Biotech
From
Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
April 18, 2023
Tickers
LLY
MKGAF
MKKGY
NKTR
Tags
Analyst Color
MKGAF
Biotech
From
Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
April 12, 2023
Tickers
MKGAF
MKKGY
Tags
Biotech
Market News
MKGAF
From
Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
March 27, 2023
Tickers
M
MKGAF
MKKGY
PFE
Tags
SGEN
MKGAF
PFE
From
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Tickers
INCY
MGNX
MKGAF
MKKGY
Tags
MRK
Small Cap
Market News
From
Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
January 03, 2023
Tickers
MKGAF
MKKGY
PDSB
Tags
Small Cap
Market News
Biotech
From
Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
December 23, 2022
Tickers
MKGAF
MKKGY
MRSN
Tags
News
Briefs
General
From
Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
September 30, 2021
Tickers
GSK
MKGAF
MKKGY
MRK
Tags
MKGAF
lung cancer
GSK
From
Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
September 21, 2021
Tickers
MKGAF
MKKGY
NKTR
PFE
Tags
NKTR
Contracts
MKKGY
From
Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
August 24, 2021
Tickers
GSK
MKGAF
MKKGY
MRK
Tags
Benzinga
News
Briefs
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.